biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Should a comparison be made between Bioasis and Denali?

<< Previous

Bullboard Posts

Next >>

Comment by Sniper007on Dec 22, 2020 3:27pm

198 Views

Post# 32162746

RE:RE:Should a comparison be made between Bioasis and Denali?

regardless wrote:

"your right... we are in the same
league as a 10.5 billion dollar company that far ahead of us into clinical trials ....."

So are you changing your tune? Previously you were indicating that Bioasis shouldn't be compared to Denali. Now you're saying we're not in the same league. What is it, regardless? Jeez, get it together man!

Yes, Bioasis (#xb3) is currently in the minors but is projected to go #1 in the draft. Scouts are projecting a breakout rookie season starting in 2021!

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments